Are non-phthalate substitute plasticizers safe? The association of urinary di-isononyl cyclohexane-1,2-dicarboxylate (DINCH) metabolites with in-vitro fertilization (IVF) outcomes: Results from the EARTH study

2016 ◽  
Author(s):  
Irene Souter
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Ivf Outcomes ◽  
The Earth

scholarly journals Association of Hexachlorobenzene (HCB), Dichlorodiphenyltrichloroethane (DDT), and Dichlorodiphenyldichloroethylene (DDE) with in Vitro Fertilization (IVF) Outcomes

2012 ◽  
Vol 120 (2) ◽  
pp. 316-320 ◽  
Author(s):  
Shruthi Mahalingaiah ◽  
Stacey A. Missmer ◽  
Arnab Maity ◽  
Paige L. Williams ◽  
John D. Meeker ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Ivf Outcomes

The relationship of hair mercury levels with early in vitro fertilization (IVF) outcomes

2010 ◽  
Vol 94 (4) ◽  
pp. S228
Author(s):  
D.L. Wright ◽  
S. Ehrlich ◽  
K. Berry ◽  
T.L. Toth ◽  
C. Amarasiriwardena ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Ivf Outcomes ◽  
Hair Mercury ◽  
Relationship Of ◽  
The Relationship

Maternal hair mercury levels and early in vitro fertilization (IVF) outcomes

2011 ◽  
Vol 96 (3) ◽  
pp. S7 ◽  
Author(s):  
D.L. Wright ◽  
K.W. Smith ◽  
S. Ehrlich ◽  
K. Berry ◽  
T.L. Toth ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Ivf Outcomes ◽  
Hair Mercury

scholarly journals Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome

2017 ◽  
Vol 45 (3) ◽  
pp. 1138-1147 ◽  
Author(s):  
Ya Chen ◽  
Bilv Ye ◽  
Xiaojing Yang ◽  
Jiujia Zheng ◽  
Jinju Lin ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Antral Follicle ◽  
Antral Follicle Count ◽  
Ovary Syndrome ◽  
Vitro Fertilization ◽  
Ivf Outcomes ◽  
Basal Serum

Objective This study evaluated associations of basal serum and follicular fluid (FF) anti-Muüllerian hormone (AMH) levels with in vitro fertilization (IVF) outcomes in polycystic ovary syndrome (PCOS) patients. Methods This prospective study included 179 consecutive women undergoing IVF, including 59 with PCOS and non-PCOS controls. Thirty PCOS cases had long gona-dotrophin-releasing hormone agonist (GnRH-a) and 29 had antagonist (GnRH-ant) protocols. Controls underwent conventional GnRH-a. Associations of basal serum and FF AMH levels with IVF outcomes were assessed. Results Median serum and FF AMH levels, antral follicle count (AFC), oestradiol human chorionic gonadotropin injection day (peak E2), and retrieved oocyte numbers were higher in PCOS patients than in controls (all P < 0.01). Oocyte maturation and high-quality embryo rates were lower in PCOS patients than in controls (P < 0.01), but both groups had similar fertilization, implantation, clinical pregnancy, and newborn rates. Peak E2 was higher in GnRH-ant than in GnRH-a protocols (16.5 nmol/L vs. 12.1 nmol/L, P < 0.05). AMH levels were correlated with AFC in PCOS patients ( P < 0.01). Peak E2 and FF AMH levels were independent predictors of oocyte number. Peak E2 predicted the fertilization rate. Conclusion Serum basal AMH levels are predictive of oocyte quantity, but not oocyte quality or IVF outcomes. Serum AMH, FF AMH, and outcomes are similar among protocols.

In-vitro fertilization (IVF) outcomes in patients with hysteroscopic fibroid resection (SMR) or polypectomy

2010 ◽  
Vol 94 (4) ◽  
pp. S220-S221
Author(s):  
L.J. Meyer ◽  
M.F. Costantini-Ferrando ◽  
G.L. Schattman ◽  
Z. Rosenwaks
Keyword(s):  
In Vitro Fertilization ◽  
Vitro Fertilization ◽  
Ivf Outcomes
Sign in / Sign up

Export Citation Format

Share Document